Artemis Medicare Services Ltd is Rated Buy

Current Rating and Its Significance

The 'Buy' rating assigned to Artemis Medicare Services Ltd indicates a positive outlook on the stock’s potential for growth and value creation. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Investors should understand that this rating suggests the stock is expected to outperform the broader market or its sector peers over the medium term, making it a favourable addition to a diversified portfolio.

Quality Assessment

As of 13 July 2026, Artemis Medicare Services Ltd demonstrates a strong quality profile. The company holds a 'good' quality grade, reflecting robust operational performance and financial health. Notably, the firm has maintained positive results for nine consecutive quarters, underscoring consistent profitability and operational stability. The operating profit to interest coverage ratio stands at a healthy 8.10 times, indicating a strong ability to service debt obligations without strain. Furthermore, the company’s debt to EBITDA ratio is a modest 1.39 times, signalling prudent leverage management and financial discipline.

Valuation Perspective

Currently, Artemis Medicare Services Ltd is considered attractively valued. The stock trades at a price-to-book value of 4.7, which, while reflecting growth expectations, remains at a discount relative to its peers’ historical valuations. This valuation is supported by a return on equity (ROE) of 11.3%, suggesting efficient utilisation of shareholder capital. The price-to-earnings-to-growth (PEG) ratio of 3.6 indicates that while the stock commands a premium for growth, it remains within reasonable bounds given the company’s earnings trajectory. This balance between growth and valuation makes the stock appealing for investors seeking both capital appreciation and value.

Financial Trend and Growth Dynamics

The latest data shows that Artemis Medicare Services Ltd has exhibited strong financial momentum. Operating profit has grown at an impressive annual rate of 59.20%, reflecting effective cost management and expanding operational scale. Net sales for the most recent quarter reached a record high of ₹279.23 crores, while PBDIT (profit before depreciation, interest, and taxes) also hit a peak of ₹51.60 crores. These figures highlight the company’s ability to generate increasing revenues and profits, reinforcing the positive financial trend that underpins the current rating.

Technical Outlook

From a technical standpoint, the stock is classified as bullish. As of 13 July 2026, Artemis Medicare Services Ltd has delivered a 1-month return of +4.71% and a 3-month return of +21.00%, signalling strong upward momentum. Over the past year, the stock has appreciated by 8.88%, outperforming the BSE500 index in each of the last three annual periods. This consistent outperformance reflects sustained investor confidence and favourable market sentiment, which are important considerations for timing entry and exit points.

Performance Summary and Market Position

Artemis Medicare Services Ltd is classified as a smallcap within the hospital sector. Despite its size, the company has demonstrated consistent returns and operational resilience. The year-to-date return stands at +1.75%, while the six-month return is +7.50%, indicating steady progress amid broader market fluctuations. The stock’s ability to outperform benchmarks such as the BSE500 over multiple years further validates its investment appeal.

Investor Implications

For investors, the 'Buy' rating on Artemis Medicare Services Ltd suggests a favourable risk-reward profile. The company’s strong fundamentals, attractive valuation, positive financial trends, and bullish technical indicators collectively support the expectation of continued growth and value creation. Investors should consider this rating as a signal to evaluate the stock for potential inclusion in their portfolios, particularly those seeking exposure to the hospital sector with a focus on companies demonstrating robust operational and financial health.

Summary of Key Metrics as of 13 July 2026

Artemis Medicare Services Ltd’s Mojo Score currently stands at 78.0, reflecting a strong overall assessment. The company’s stock returns over various periods are as follows: 1 day at -0.52%, 1 week at -0.20%, 1 month at +4.71%, 3 months at +21.00%, 6 months at +7.50%, year-to-date at +1.75%, and 1 year at +8.88%. These figures demonstrate a resilient performance trajectory, supported by solid operational growth and market confidence.

Debt and Profitability Metrics

The company’s low debt to EBITDA ratio of 1.39 times indicates manageable leverage, reducing financial risk. Operating profit growth at an annualised rate of 59.20% highlights strong earnings momentum. The highest quarterly net sales of ₹279.23 crores and PBDIT of ₹51.60 crores further reinforce the company’s expanding scale and profitability. An ROE of 11.3% confirms efficient capital utilisation, while the attractive valuation metrics suggest the stock is reasonably priced relative to its growth prospects.

Outperformance and Market Standing

Artemis Medicare Services Ltd has consistently outperformed the BSE500 index over the last three years, delivering superior returns and demonstrating resilience in varying market conditions. This consistent track record is a key factor supporting the current 'Buy' rating and highlights the company’s competitive positioning within the hospital sector.

Conclusion

In conclusion, Artemis Medicare Services Ltd’s 'Buy' rating by MarketsMOJO reflects a well-rounded investment case grounded in strong quality, attractive valuation, positive financial trends, and bullish technical indicators. Investors seeking exposure to a smallcap hospital sector stock with consistent growth and solid fundamentals may find this company a compelling opportunity. The current data as of 13 July 2026 confirms the stock’s favourable outlook and supports its inclusion in growth-oriented portfolios.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today